financetom
Business
financetom
/
Business
/
What's Going On With Shopify Stock Monday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Shopify Stock Monday?
Nov 11, 2024 10:52 AM

Shopify Inc. ( SHOP ) shares are trending and moving higher on Monday. The company is due to release earnings before the market opens on Tuesday. Here’s what you need to know.

What To Know: Shopify ( SHOP ) is expected to release third-quarter financial results before the opening bell on Tuesday. Analysts anticipate earnings per share of 27 cents and revenue of $2.11 billion, per estimates from Benzinga Pro. Revenue in the comparable quarter came in at $1.71 billion.

In the second quarter, Shopify ( SHOP ) surpassed analyst estimates for revenue and earnings per share. The company reported earnings per share of 26 cents, beating analyst estimates of 20 cents, and revenue of $2.04 billion, beating analyst estimates of $2.01 billion.

Shopify ( SHOP ) said last quarter that it expected revenue to grow in the low-to-mid twenties percentage range on a year-over-year basis. Shopify ( SHOP ) also guided for operating expenses to be between 41% and 42% of revenue. The company expects gross margin to be higher by about 50 basis points compared to the second quarter.

“We are proud to report another quarter of robust financial performance. We drove strong growth in GMV, revenue, and gross profit, all amidst a mixed consumer spend environment, continued to take share and concurrently expanded our free cash flow margin. We delivered across every metric,” Shopify CFO Jeff Hoffmeister said last quarter.

“Our results underscore our commitment to providing exceptional value to our merchants through focused operating execution and efficiency. As a high-growth global technology leader in commerce, we remain committed to leveraging our core strengths and investing in opportunities to achieve sustainable growth and long-term profitability.”

Multiple analysts have lifted price targets on Shopify ( SHOP ) stock over the last month leading up to earnings. Near the end of October, Scotiabank analyst Kevin Krishnaratne raised the firm’s price target from $75 to $80. RBC Capital also raised its target from $85 to $100 last month, Loop Capital moved from $80 to $90 and Baird raised its target from $79 to $90.

See Also: Warren Buffett’s Apple Stake Reduction Spurs $97B Cash Surge—Analysts Speculate This Could Be The Reason Behind Berkshire Hathaway’s Massive Cash Pile

SHOP Price Action: At the time of writing, Shopify ( SHOP ) shares were up 3.98% at $90.59, according to data from Benzinga Pro.

Image: Photo via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tetra Tech Q4 adjusted EPS beats estimates
Tetra Tech Q4 adjusted EPS beats estimates
Nov 12, 2025
Overview * Adjusted EPS for Q4 beats analyst expectations, increasing 29% yr/yr * Company repurchased $50 mln of common stock in Q4 Outlook * Tetra Tech expects fiscal 2026 net revenue between $4.05 bln and $4.25 bln * Tetra Tech sees fiscal 2026 EPS between $1.40 and $1.55 * Company anticipates Q1 fiscal 2026 net revenue between $950 mln and...
Edgewell Personal Care Announces Sale of Feminine Care Business to Essity for $340M
Edgewell Personal Care Announces Sale of Feminine Care Business to Essity for $340M
Nov 12, 2025
Transaction streamlines Edgewell's portfolio and allows the personal care brand to focus on areas of competitive leadership SHELTON, Conn., Nov. 12, 2025 /PRNewswire/ -- Edgewell Personal Care Company ( EPC ) today announced that it has entered into a definitive agreement to sell its feminine care business to Essity, a leading global health and hygiene company based in Sweden,...
MacroGenics Q3 revenue declines, secures $75 mln in partnerships
MacroGenics Q3 revenue declines, secures $75 mln in partnerships
Nov 12, 2025
Overview * MacroGenics ( MGNX ) Q3 revenue declines 34.2% yr/yr * Company secures $75 mln in partnering proceeds from Sanofi and Gilead * MacroGenics ( MGNX ) ends lorigerlimab prostate cancer development, continues ovarian cancer focus Outlook * MacroGenics ( MGNX ) extends cash runway guidance into late 2027 * Company continues development of lorigerlimab in ovarian cancer *...
Merck & Co. Insider Sold Shares Worth $616,395, According to a Recent SEC Filing
Merck & Co. Insider Sold Shares Worth $616,395, According to a Recent SEC Filing
Nov 12, 2025
04:12 PM EST, 11/12/2025 (MT Newswires) -- Cristal N Downing, Chief Communications & Public Affairs Officer, on November 10, 2025, sold 7,085 shares in Merck & Co. ( MRK ) for $616,395. SEC Filing: https://www.sec.gov/Archives/edgar/data/310158/000031015825000061/xslF345X05/form4.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved